Boekhorst Paul Francis Olivier te insider trades: Immucell (ICCC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Boekhorst reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | ICCC | ↑ Buy | 8,000 | $9.49 | $76K | Direct | Jun 22, 2026 (4d) |
| Dec 3, 2025 | ICCC | ↑ Buy | 9,785 | $4.97 | $49K | Direct | Dec 3, 2025 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ICCC insiders
Open-market trades in the last 12 months
About Boekhorst Paul Francis Olivier te's insider trades
Boekhorst Paul Francis Olivier te is President and CEO at Immucell (ICCC). Since Dec 3, 2025, Boekhorst has reported 2 open-market purchases worth $125K and no sales on SEC Form 4. In the last 12 months: 2 buys ($125K).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ICCC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.